Financhill
Back

Design Therapeutics Stock Predictions

Design Therapeutics Stock Forecast

  • Is Design Therapeutics Stock Undervalued?
    The current Design Therapeutics [DSGN] share price is $3.72. The Score for DSGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • DSGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Design Therapeutics Stock Go Up Next Year?

Data Unavailable

Design Therapeutics Stock Rating

Data Unavailable

Design Therapeutics Stock Price History

Is DSGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com

52-Week Data

52-Week High:
8.47
52-Week Low:
1.94

Prediction Charts

Market Cap:
210.16M
Price in USD:
3.72
Volume:
173.98K
Beta:
1.86

Technical Analysis

SMA50:
3.37
SMA100:
2.93
SMA200:
3.07
52-Wk Change:
-48.26%

Stock Predictions

  • Is Design Therapeutics stock public?
    Yes, Design Therapeutics is a publicly traded company.
  • What is the Design Therapeutics stock quote today?
    The Design Therapeutics stock price is 3.72 USD today.
  • How to buy Design Therapeutics stock online?
    You can buy Design Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 3.76 3.69 3.79 3.64
Apr-17 3.71 3.94 4.13 3.71
Apr-18 3.91 3.75 3.97 3.73
Apr-19 3.72 3.69 3.90 3.68
Apr-22 3.71 3.90 3.95 3.61
Apr-23 3.88 3.66 3.97 3.64
Apr-24 3.58 3.65 3.73 3.55
Apr-25 3.55 3.76 3.79 3.51
Apr-26 3.77 3.78 3.80 3.70
Apr-29 3.81 3.72 3.94 3.69
Apr-30 3.67 3.52 3.71 3.51
May-1 3.54 3.61 3.75 3.54
May-2 3.69 3.65 3.70 3.55
May-3 3.76 3.72 3.83 3.65

Design Therapeutics Earnings

Data Unavailable

Design Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.14 per share, and a decrease next year of $0.24 per share.

* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.